Cryopreservation of cerebrospinal fluid cells preserves the transcriptional landscape for single-cell analysis

Mahesh Chandra Kodali,Jerry Antone,Eric Alsop,Rojashree Jayakumar,Khushi Parikh,Aude Chiot,Paula Sanchez-Molina,Bahareh Ajami,Steven E. Arnold,Kendall Jensen,Sudeshna Das,Marc S. Weinberg
DOI: https://doi.org/10.1186/s12974-024-03047-1
IF: 9.3
2024-03-25
Journal of Neuroinflammation
Abstract:Cerebrospinal fluid (CSF) matrix biomarkers have become increasingly valuable surrogate markers of neuropsychiatric diseases in research and clinical practice. In contrast, CSF cells have been rarely investigated due to their relative scarcity and fragility, and lack of common collection and cryopreservation protocols, with limited exceptions for neurooncology and primary immune-based diseases like multiple sclerosis. the advent of a microfluidics-based multi-omics approach to studying individual cells has allowed for the study of cellular phenotyping, intracellular dynamics, and intercellular relationships that provide multidimensionality unable to be obtained through acellular fluid-phase analyses. challenges to cell-based research include site-to-site differences in handling, storage, and thawing methods, which can lead to inaccuracy and inter-assay variability. In the present study, we performed single-cell RNA sequencing (10x Genomics) on fresh or previously cryopreserved human CSF samples from three alternative cryopreservation methods: Fetal Bovine Serum with Dimethyl sulfoxide (FBS/DMSO), FBS/DMSO after a DNase step (a step often included in epigenetic studies), and cryopreservation using commercially available Recovery© media. In comparing relative differences between fresh and cryopreserved samples, we found little effect of the cryopreservation method on being able to resolve donor-linked cell type proportions, markers of cellular stress, and overall gene expression at the single-cell level, whereas donor-specific differences were readily discernable. We further demonstrate the compatibility of fresh and cryopreserved CSF immune cell sequencing using biologically relevant sexually dimorphic gene expression differences by donor. Our findings support the utility and interchangeability of FBS/DMSO and Recovery cryopreservation with fresh sample analysis, providing a methodological grounding that will enable researchers to further expand our understanding of the CSF immune cell contributions to neurological and psychiatric disease.
immunology,neurosciences
What problem does this paper attempt to address?
### The problems that the paper attempts to solve This paper aims to explore whether the transcriptome characteristics of cerebrospinal fluid (CSF) cells can maintain their original state under different cryopreservation methods, so as to provide reliable samples for single - cell analysis. Specifically, the main research questions include: 1. **The impact of cryopreservation on CSF cells**: Researchers hope to evaluate whether cryopreservation will affect cell - type ratios, cell stress markers, and overall gene - expression patterns by comparing freshly - collected CSF cells with CSF cells treated by different cryopreservation methods. 2. **The choice of cryopreservation methods**: Researchers tested three different cryopreservation methods: - Fetal bovine serum plus dimethyl sulfoxide (FBS/DMSO) - FBS/DMSO combined with DNase treatment (for epigenetic research) - Commercial Recovery© medium 3. **Consistency across samples**: Researchers hope to verify the consistency of results between different cryopreservation methods and between fresh samples, ensuring that these methods can be used in multi - center studies and reducing batch effects and variability between experiments. 4. **Biological relevance**: Researchers also further verify whether cryopreserved CSF cells can retain biologically significant differences through biomarkers such as sex - differential gene expression. ### Research background As an important source of biomarkers for neuropsychiatric diseases, cerebrospinal fluid (CSF) has been widely used in research and clinical practice in recent years. However, due to the scarcity and fragility of CSF cells and the lack of unified collection and cryopreservation standards, there are relatively few studies on it. With the development of microfluidic technology, multi - omics methods such as single - cell RNA sequencing (scRNAseq) have made it possible to study CSF cells, but transcriptome changes may be introduced during the cryopreservation process, affecting the reliability of experimental results. Therefore, this study aims to provide a reliable methodological basis for future research by systematically comparing multiple cryopreservation methods and promote the application of CSF cells in nervous system and psychiatric diseases.